Cite
Kumari S, Bubak M, Schoenberg HM, et al. Antecedent Metabolic Health and Metformin (ANTHEM) Aging study: Rationale and study design for a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2021;doi: 10.1093/gerona/glab358.
Kumari, S., Bubak, M., Schoenberg, H. M., Davidyan, A., Elliehausen, C. J., Kuhn, K. G., VanWagoner, T. M., Karaman, R., Scofield, R. H., Miller, B. F., & Konopka, A. R. (2021). Antecedent Metabolic Health and Metformin (ANTHEM) Aging study: Rationale and study design for a randomized controlled trial. The journals of gerontology. Series A, Biological sciences and medical sciences, . https://doi.org/10.1093/gerona/glab358
Kumari, Santosh, et al. "Antecedent Metabolic Health and Metformin (ANTHEM) Aging study: Rationale and study design for a randomized controlled trial." The journals of gerontology. Series A, Biological sciences and medical sciences vol. (2021). doi: https://doi.org/10.1093/gerona/glab358
Kumari S, Bubak M, Schoenberg HM, Davidyan A, Elliehausen CJ, Kuhn KG, VanWagoner TM, Karaman R, Scofield RH, Miller BF, Konopka AR. Antecedent Metabolic Health and Metformin (ANTHEM) Aging study: Rationale and study design for a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2021 Dec 02; doi: 10.1093/gerona/glab358. Epub 2021 Dec 02. PMID: 34865016.
Copy
Download .nbib